New patent for Therakind drug JYLAMVO

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for JYLAMVO
Annual Drug Patent Expirations for JYLAMVO

Jylamvo is a drug marketed by Therakind and is included in one NDA. There is one patent protecting this drug.

This drug has sixteen patent family members in seventeen countries.

The generic ingredient in JYLAMVO is methotrexate. Additional details are available on the methotrexate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top